Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today commented on recent stock price volatility ...

Firms downgrade 2025 outlook, isocyanate start-up launches, hydrogen projects advance, and more ...

Constellium developed the project's modular sill concept using aluminum extrusions made from its HSA6 high-strength aluminum ...

After more than a year in operation, the system retains 98% of usable capacity, indicating minimal degradation and strong ...

A middle school design and technology teacher breaks down a three-project unit that nicely overlaps with STEAM content.

In the first half of 2025, all segments of the sodium-ion battery industry chain demonstrated significant growth. However, ...

Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves — insights that could help ...

DelveInsight's, “Oncolytic Virus Cancer Therapy Pipeline Insight, 2025,” report provides comprehensive insights about 120+ companies and 125+ pipeline drugs in Oncolytic Virus Cancer Therapy pipeline ...

Piersica announces it secured an Army SBIR Phase II contract worth approximately $1.9M to further develop its ultra-high ...

There is no evidence the footage was deceptively manipulated, but ambiguities around how the video was processed may further ...

In the first half of 2025, all segments of the sodium-ion battery industry chain demonstrated significant growth. However, the industry also faced concurrent challenges of technological route changes, ...

The authors proposed two hypotheses: first, that methamphetamine induces neuroinflammation, and second, that it alters neuronal stem cell differentiation. These are valuable hypotheses, and the ...